Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Easy payday advance loans, payday loan in USA.
Popular Articles
Cellulite Cream

U.S. Hospitals Feeling The Squeeze During Economic Recession
The recession is taking a toll on the hospital industry as "cash-strapped patients are skipping visits and under-compensated cases are increasing," Forbes reports. "As a result, a pattern of cost-cutting has emerged as hospitals have tried not to sacrifice quality, access and safety." In addition, "There has also been the elimination of entire departments as well as often subsidized services like mental health. Such cuts, which can translate into longer wait times, less up-to-date technology and fewer services, are bound to affect patients."
generic viagra online
Early Screening Reduces Disparities For Prostate Cancer
Men who have a regular, ongoing relationship with a health care provider are more likely to receive prostate cancer screening and less likely to be diagnosed with advanced prostate cancer, regardless of their race, according to a University of North Carolina study published in the current issue of the journal Cancer.
News of the day
New Publication Indian Journal Of Surgical Oncology To Be Launched By Springer
Springer, one of the leading publishers in the fields of science, technology and medicine, has signed a co-publishing agreement with the Indian Association of Surgical Oncology (IASO), to launch the society"s official publication, the Indian Journal of Surgical Oncology (IJSO). Dr. Vijay Kumar, Secretary of the Indian Association of Surgical Oncology; Dr. K.S. Gopinath, editor of the IIndian Journal of Surgical Oncology; Dr. William F. Curtis, President of Springer Science+Business Media, LLC; and Sanjiv Goswami, Managing Director of Springer India, signed the agreement at Bangalore.
Diagnostics

ACCP Position Paper On Genetic Tests Advertised Directly To The Consumer

Genetic testing services have recently begun to be advertised directly to the patient, and the results of the consumers" response can affect public health, as well as the future adoption of pharmacogenetic/genomic testing, according to a position paper from the American College of Clinical Pharmacology (ACCP) to be published in the August 2009 issue of the Journal of Clinical Pharmacology. The journal is published on behalf of the ACCP by SAGE. According to the article, "Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology," prescription medications have been advertised in the US for 10+ years with a defined oversight of the process, however, there"s no comparable supervision for advertised genetic testing. In order for the consumer to have a positive experience with choosing genetic testing from advertising, clinical pharmacologists believe that effective governmental oversight is imperative, along with assistance from professional clinicians. Clinical pharmacologists should also help prepare consumers for possible risks of the tests and work closely with those who are considering taking further action in response to an advertisement of genetic testing, providing the following cautionary advice: * Verify with a professional, the information presented in advertisements of genetic testing * Seek advice from a genetic clinician, not just a general health care professional * Recognize the scientific limitations of each test, especially since the information isn"t necessarily translatable when it"s time to make therapeutic decisions. * Realize that many companies selling genetic testing services do not provide interpretation of results. Commenting on the expanding frontiers of health professions, the authors conclude, "Clinical pharmacology will have a voice in how the evolving science translates not only into clinical trials and patient care but also into regulations involving the promotion and advertising of all genetic tests. Clinical pharmacologists can help ensure that realistic expectations of genetic tests are communicated, thereby mitigating psychological, social, and medical risks." "Direct-to-Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology" by Barbara Ameer, PharmD, MBA, of the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, and Norberto Krivoy, MD, of the Center for Translational Genetics, B. Rappaport Institute for Research in Medical Sciences, and Clinical Pharmacology Institute, Rambam Health Care Campus and Technion - Israel Institute of Technology, is being made available free of charge for a limited time at http://jcp.sagepub.com/cgi/content/full/49/8/886. Jim Gilden SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009